WELLS FARGO & COMPANY/MN - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 36 filers reported holding NRX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,399
-45.8%
5,379
+0.7%
0.00%
Q2 2023$2,582
-26.2%
5,340
+0.6%
0.00%
Q1 2023$3,500
-40.5%
5,309
+0.1%
0.00%
Q4 2022$5,887
+47.2%
5,304
+0.2%
0.00%
Q3 2022$4,000
+33.3%
5,292
+1.1%
0.00%
Q2 2022$3,000
-75.0%
5,232
+4.6%
0.00%
Q1 2022$12,000
-50.0%
5,0000.0%0.00%
Q4 2021$24,000
-47.8%
5,0000.0%0.00%
Q3 2021$46,0005,0000.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 325,000$84,5000.06%
Texas Capital Bank Wealth Management Services Inc 63,290$16,4550.00%
XTX Topco Ltd 11,809$3,0700.00%
United Asset Strategies, Inc. 18,300$4,7580.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 160,700$41,7820.00%
UBS Group AG 1,210$3150.00%
NewEdge Advisors, LLC 7,125$1,8530.00%
Lido Advisors, LLC 13,000$3,3800.00%
OSAIC HOLDINGS, INC. 11,125$2,8910.00%
WELLS FARGO & COMPANY/MN 5,379$1,3990.00%
View complete list of NRX PHARMACEUTICALS INC shareholders